Equity Capital And Reserves Alterar Data
Amgen USD 6.23B 1.42B 2023-12
Arrowhead Research USD 160.41M 110.94M 2023-12
AstraZeneca USD 37.2B 195M 2023-09
BioMarin Pharmaceutical USD 4.95B 54.65M 2023-12
Bristol-Myers Squibb USD 29B 2.98B 2023-09
Celldex Therapeutics USD 429.17M 182.45M 2023-12
Daiichi Sankyo JPY 1.59T 64.13B 2023-09
Eli Lilly USD 11.22B 156.6M 2023-09
Halozyme Therapeutics USD 83.81M 165.37M 2023-12
Heron Therapeutics USD -27786000 11.5M 2023-09
Intrexon USD 147.68M 18.53M 2023-09
Ionis Pharmaceuticals USD 386.69M 71.23M 2023-12
Ligand Pharmaceuticals USD 700.91M 33.02M 2023-12
Neurocrine Biosciences USD 2B 149.1M 2023-09
Pfizer USD 96.93B 2.08B 2023-09
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Rigel Pharmaceuticals USD -31834000 3.72M 2023-09
Ultragenyx Pharmaceutical USD 275.41M 243.7M 2023-12
Veracyte USD 1.04B 9.96M 2023-12



Rigel Pharmaceuticals Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.